Buscas alternativas:
costs processing » cost processing (Expandir a busca), post processing (Expandir a busca), codas processing (Expandir a busca)
decrease costs » decreasing costs (Expandir a busca), decreases post (Expandir a busca), disease costs (Expandir a busca)
decrease drugs » disease drugs (Expandir a busca), decrease treg (Expandir a busca), release drugs (Expandir a busca)
drugs decrease » drugs increases (Expandir a busca), drugs release (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease by » decreased by (Expandir a busca), decrease in (Expandir a busca), decrease of (Expandir a busca)
by decrease » by decreased (Expandir a busca), may decrease (Expandir a busca), any decrease (Expandir a busca)
costs processing » cost processing (Expandir a busca), post processing (Expandir a busca), codas processing (Expandir a busca)
decrease costs » decreasing costs (Expandir a busca), decreases post (Expandir a busca), disease costs (Expandir a busca)
decrease drugs » disease drugs (Expandir a busca), decrease treg (Expandir a busca), release drugs (Expandir a busca)
drugs decrease » drugs increases (Expandir a busca), drugs release (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease by » decreased by (Expandir a busca), decrease in (Expandir a busca), decrease of (Expandir a busca)
by decrease » by decreased (Expandir a busca), may decrease (Expandir a busca), any decrease (Expandir a busca)
1
“... is traumatic for the patients, involving high costs and might require repetition of the procedure. Therefore...”
Acessar documento
Acessar documento
2
“... prevalent markers) would considerably decrease the processing costs while retaining diagnostic accuracy....”
Acessar documento
Acessar documento
Artigo
3
4
“... necrosis factor (anti-TNF), infliximab, adalimumab and etanercept. However, these drugs were not previously...”
Acessar documento
Acessar documento
Tese
5